Kahn B B
Charles A. Dana Research Institute, Beth Israel Hospital, Boston, Massachusetts 02215.
J Cell Biochem. 1992 Feb;48(2):122-8. doi: 10.1002/jcb.240480203.
Insulin resistance is a major pathologic feature of human obesity and diabetes. Understanding the fundamental mechanisms underlying this insulin resistance has been advanced by the recent cloning of the genes encoding a family of facilitated diffusion glucose transporters which are expressed in characteristic patterns in mammalian tissues. Two of these transporters, GLUT1 and GLUT4, are present in muscle and adipose cells, tissues in which glucose transport is markedly stimulated by insulin. To understand the mechanisms underlying in vivo insulin resistance, regulation of these transporters is being investigated. Studies reveal divergent changes in the expression of GLUT1 and GLUT4 in a single cell type as well as tissue specific regulation. Importantly, alterations in glucose transport in rodent models of diabetes and in human obesity and diabetes cannot be entirely explained by changes in glucose transporter expression. This suggests that defects in glucose transporter function such as impaired translocation, fusion with the plasma membrane, or activation probably contribute importantly to in vivo insulin resistance.
胰岛素抵抗是人类肥胖症和糖尿病的主要病理特征。近期克隆出了编码一类易化扩散葡萄糖转运蛋白家族的基因,这些基因在哺乳动物组织中呈特征性表达模式,这推动了对胰岛素抵抗潜在基本机制的理解。其中两种转运蛋白,即葡萄糖转运蛋白1(GLUT1)和葡萄糖转运蛋白4(GLUT4),存在于肌肉和脂肪细胞中,在这些组织中,葡萄糖转运受到胰岛素的显著刺激。为了理解体内胰岛素抵抗的潜在机制,正在对这些转运蛋白的调节进行研究。研究揭示了在单一细胞类型中GLUT1和GLUT4表达的不同变化以及组织特异性调节。重要的是,糖尿病啮齿动物模型以及人类肥胖症和糖尿病中葡萄糖转运的改变不能完全由葡萄糖转运蛋白表达的变化来解释。这表明葡萄糖转运蛋白功能缺陷,如转运受损、与质膜融合或激活受损,可能对体内胰岛素抵抗起重要作用。